Dow Up 0.11% Nasdaq Up 0.50%

ChemoCentryx, Inc. (CCXI)

-NasdaqGS
5.11 Up 0.08(1.59%) Aug 29, 4:00PM EDT
|After Hours : 5.11 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Prev Close:5.03
Open:5.03
Bid:N/A
Ask:6.09 x 100
1y Target Est:8.33
Beta:1.19
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:5.01 - 5.13
52wk Range:4.57 - 8.46
Volume:52,243
Avg Vol (3m):311,623
Market Cap:221.44M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CCXI

Comparison

Symbol% ChgMkt Cap
CCXIUp 1.59%221.44M
ABTDown 0.26%63.52B
AMGNUp 0.50%105.87B
AZNUp 2.38%96.00B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):97.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.14
Quarterly EPS Est (Sep-14) :-0.28
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback